Mankind Pharma
MANKIND · Pharma > Pharmaceuticals & Drugs Listing date: May 9, 2023

Stock Price vs Company Growth
1d
2.8%
1w
8.7%
1m
19.6%
3m
18.6%
6m
7.9%
1y
0.4%
all
19.7%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 2,442 2.8%
1,910
2,464
Company Overview

Sales
13,914 Cr
Growth: 19.7%
Profit after Tax
1,779 Cr
Growth: 1.6%
Large Cap
1,00,817 Cr
P/E: 56.6x
Industry P/E: 30.4x
Fundamentals

Sales (Cr) ₹ 13,914
Growth 19.7%
EBITDA 24.2%
P/S 7.2x
Dividend 0.0%
P/E 56.6x
Book Value ₹ 380
PEG Ratio 2.9x
ROE 11.8%
P/B 6.5x
Shareholding Pattern

Increase    Decrease    No change
Company Profile Detailed

The company is India’s one of the leading pharmaceutical company with a diversified portfolio - from pharma and super specialty to consumer healthcare backed by strong in-house R&D capabilities with an established and deeply penetrated presence across India. The company is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products.
Investors (1)
Followers (2)